Transplant Diagnostics Market

Transplant Diagnostics Market (Screening: Pre-transplant Diagnostics and Post-transplant Diagnostics; and Technique: Molecular Assay and Non-molecular Assay) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transplant Diagnostics Market Outlook 2031

  • The global industry was valued at US$ 1.2 Bn in 2022
  • It is expected to grow at a CAGR of 7.7% from 2023 to 2031 and reach US$ 2.3 Bn by the end of 2031

Analyst Viewpoint

Increase in focus on early profiling during organ transplantation and rise in incidence of chronic kidney disorders are propelling the transplant diagnostics market size. Early profiling and organ transplant monitoring are gaining traction among healthcare professionals to minimize the risk of rejection and improve overall transplant outcomes.

Transplantation is a viable and often preferred treatment option for patients suffering from chronic kidney diseases. R&D in noninvasive transplant diagnostic methods, immunosuppressive medications, and post-transplant care is likely to offer lucrative opportunities to players in the global transplant diagnostics industry. Vendors are developing novel assays and antigen products to expand their product portfolio.

Transplant Diagnostics Market

Market Introduction

Transplant diagnostics are tests and procedures performed before, during, and after organ transplantation. They ensure the compatibility between the donor organ and the recipient's immune system. Rise in risk of organ rejection is boosting demand for transplant diagnostics.

Organizations across the globe are promoting organ harvesting, which is fueling the number of donated organs. Next Generation Sequencing (NGS) technology has had a significant impact on organ transplantation. NGS is utilized for high-resolution typing of Human Leukocyte Antigens (HLA), which are crucial for immune system compatibility.

High costs associated with transplant diagnostic procedures, such as histocompatibility tests, genomic profiling, and blood profiling, are projected to limit the transplant diagnostics market growth in the near future. These procedures are conducted through exclusive molecular diagnostic platforms, which leads to high costs. Moreover, there are various challenges in integrating these technologies with traditional PCR/NGS instruments. There is a noticeable gap between the number of organs needed and the number of organs donated. These factors are estimated to restrain the transplant diagnostics industry progress during the forecast period.

Increase in Focus on Early Profiling During Organ Transplantation

Healthcare professionals are relentlessly investigating the potential of biomarkers in organ transplantation for improving patient outcomes and the overall success of transplant procedures. Biomarkers provide valuable information about the status of the transplanted organ and the recipient's immune response.

Rise in focus on early profiling during organ transplantation is boosting demand for transplant diagnostics. Early profiling involves the systematic assessment of various factors including genetic, molecular, and clinical markers. It helps healthcare professionals to draft patient-specific transplant procedures and post-transplant care. Hence, growth in focus on demonstration and validation of the clinical utility of biomarkers is driving the transplant diagnostics market trajectory.

Rise in Incidence of Chronic Kidney Disorders

Chronic kidney disease implies a progressive condition that affects more than 10% of the global population. The disease is more prevalent among women, elderly people, and those suffering from hypertension and diabetes mellitus. The adversities related to chronic kidney diseases require improvised efforts for better treatment. Kidney transplantation kidney transplantation improves the quality of life compared to long-term dialysis. As per the National Institute of Diabetes and Digestive and Kidney Disequencingases (NIDDK), 661,000 people in the U.S. suffer from kidney failure. Thus, surge in cases of chronic kidney disease is driving the transplant diagnostics market expansion.

Regional Outlook

According to the latest transplant diagnostics market trends, North America held largest share in 2022. Rise in investment in R&D for organ transplantation is fueling the market dynamics of the region. According to The National Institute of Health, funding for research in transplantation was US$ 735 Mn in 2022. Additionally, as per the Organ Donation Statistics, over 40,000 organ transplantations were conducted in the U.S. in 2021.

According to the latest transplant diagnostics market forecast, the industry in Europe is estimated to grow at a steady pace during the forecast period. Rise in expenditure in healthcare sector and availability of smoother applications in all transplantation processes and donor-recipient relationships are boosting the market landscape in Europe.

Increase in investment in advanced healthcare infrastructure is propelling the transplant diagnostics market value in Asia Pacific. India and China are major markets for transplant diagnostics due to growth in prevalence of chronic diseases. However, cultural considerations in Hong Kong, Japan, and Philippines may impact attitudes toward organ transplantation. People in these countries emphasize ancestor worship and respect for the deceased and do not believe in parting with their organs after death.

Analysis of Key Players

Major players are investing in R&D and launch of new products to expand their product portfolio and increase their transplant diagnostics market share. Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Becton, Dickinson, and Company, Ortho Clinical Diagnostics, Immucor, Inc., Illumina, Inc., Siemens Healthineers, and Agilent Technologies are major companies operating in this market.

These companies have been profiled in the transplant diagnostics industry report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments

  • In February 2023, Beton, Dickinson and Company announced that the U.S. FDA approved BD Onclarity HPV Assay for use in conjunction with ThinPrep Pap Test
  • In May 2022, Hologic received approval from the U.S. FDA for the Aptima CMV Quant assay, an assay to quantify the viral load of cytomegalovirus (CMV) in patients who have had solid organ or stem cell transplants
  • In March 2022, Immucor, Inc. added two new products to its transplant diagnostics portfolio with the launch of launch of MIA FORA NGS EXPRESS HLA Typing Software and Luminex single antigen product, LIFECODES LSATM Class I and Class II Assays

Transplant Diagnostics Market Snapshot

Attribute Detail
Market Size in 2022 US$ 1.2 Bn
Market Forecast (Value) in 2031 US$ 2.3 Bn
Growth Rate (CAGR) 7.7%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Screening
    • Pre-transplant Diagnostics
    • Post-transplant Diagnostics
  • Technique
    • Molecular Assay
    • Non-molecular Assay
  • Application
    • Solid Organ Transplantation
      • Kidney
      • Liver
      • Heart
      • Lungs
      • Pancreas
      • Small Bowel
    • Stem Cell Transplantation
  • Product & Services
    • Reagents & Consumables
    • Instruments
    • Software & Services
  • End-user
    • Hospitals & Transplant Centers
    • Research Laboratories
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia & CIS
  • China
  • India
  • Japan
  • ASEAN
  • Brazil
  • Mexico
  • GCC
  • South Africa
Companies Profiled
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson, and Company
  • Ortho Clinical Diagnostics
  • Immucor, Inc.
  • Illumina, Inc.
  • Siemens Healthineers
  • Agilent Technologies
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the transplant diagnostics market in 2022?

It was valued at US$ 1.2 Bn in 2022

How is the transplant diagnostics business expected to grow during the forecast period?

It is projected to grow at a CAGR of 7.7% from 2023 to 2031

What are the key factors driving the demand for transplant diagnostics?

Increase in focus on early profiling during organ transplantation and rise in incidence of chronic kidney disorders

Which region is expected to dominate the transplant diagnostics sector?

North America is estimated to dominate in the next few years

Who are the key transplant diagnostics manufacturers?

Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Becton, Dickinson, and Company, Ortho Clinical Diagnostics, Immucor, Inc., Illumina, Inc., Siemens Healthineers, and Agilent Technologies

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Transplant Diagnostics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Screening, 2017–2031

            6.3.1. Pre-transplant Diagnostics

            6.3.2. Post-transplant Diagnostics

        6.4. Market Attractiveness, by Screening

    7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Technique, 2017–2031

            7.3.1. Molecular Assay

            7.3.2. Non-molecular Assay

            7.3.3. 7.4 Market Attractiveness, by Technique

    8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Application, 2017–2031

            8.3.1. Solid Organ Transplantation

                8.3.1.1. Kidney

                8.3.1.2. Liver

                8.3.1.3. Heart

                8.3.1.4. Lungs

                8.3.1.5. Pancreas

                8.3.1.6. Small Bowel

            8.3.2. Stem Cell Transplantation

        8.4. Market Attractiveness, by Application

    9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by Products & Services, 2017–2031

            9.3.1. Reagents & Consumables

            9.3.2. Instruments

            9.3.3. Software & Services

        9.4. Market Attractiveness, by Products & Services

    10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

        10.1. Introduction and Definitions

        10.2. Key Findings/Developments

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals & Transplant Centers

            10.3.2. Research Laboratories

            10.3.3. Others

        10.4. Market Attractiveness, by End-user

    11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

        11.1. Key Findings

        11.2. Market Value Forecast, by Region, 2017–2031

            11.2.1. North America

            11.2.2. Europe

            11.2.3. Asia Pacific

            11.2.4. Latin America

            11.2.5. Middle East & Africa

        11.3. Market Attractiveness, by Region

    12. North America Transplant Diagnostics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Screening, 2017–2031

            12.2.1. Pre-transplant Diagnostics

            12.2.2. Post-transplant Diagnostics

        12.3. Market Attractiveness, by Screening

        12.4. Market Value Forecast, by Technique, 2017–2031

            12.4.1. Molecular Assay

            12.4.2. Non-molecular Assay

        12.5. Market Attractiveness, by Technique

        12.6. Market Value Forecast, by Application, 2017–2031

            12.6.1. Solid Organ Transplantation

                12.6.1.1. Kidney

                12.6.1.2. Liver

                12.6.1.3. Heart

                12.6.1.4. Lungs

                12.6.1.5. Pancreas

                12.6.1.6. Small Bowel

            12.6.2. Stem Cell Transplantation

        12.7. Market Attractiveness, by Application

        12.8. Market Value Forecast, by Products & Services, 2017–2031

            12.8.1. Reagents & Consumables

            12.8.2. Instruments

            12.8.3. Software & Services

        12.9. Market Attractiveness, by Products & Services

        12.10. Market Value Forecast, by End-user, 2017–2031

            12.10.1. Hospitals & Transplant Centers

            12.10.2. Research Laboratories

            12.10.3. Others

        12.11. Market Attractiveness, by End-user

        12.12. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.12.1. U.S.

            12.12.2. Canada

        12.13. Market Attractiveness Analysis

            12.13.1. By Screening

            12.13.2. By Technique

            12.13.3. By Application

            12.13.4. By Products & Services

            12.13.5. By End-user

            12.13.6. By Country

    13. Europe Transplant Diagnostics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Screening, 2017–2031

            13.2.1. Pre-transplant Diagnostics

            13.2.2. Post-transplant Diagnostics

        13.3. Market Attractiveness, by Screening

        13.4. Market Value Forecast, by Technique, 2017–2031

            13.4.1. Molecular Assay

            13.4.2. Non-molecular Assay

        13.5. Market Attractiveness, by Technique

        13.6. Market Value Forecast, by Application, 2017–2031

            13.6.1. Solid Organ Transplantation

                13.6.1.1. Kidney

                13.6.1.2. Liver

                13.6.1.3. Heart

                13.6.1.4. Lungs

                13.6.1.5. Pancreas

                13.6.1.6. Small Bowel

            13.6.2. Stem Cell Transplantation

        13.7. Market Attractiveness, by Application

        13.8. Market Value Forecast, by Products & Services, 2017–2031

            13.8.1. Reagents & Consumables

            13.8.2. Instruments

            13.8.3. Software & Services

        13.9. Market Attractiveness, by Products & Services

        13.10. Market Value Forecast, by End-user, 2017–2031

            13.10.1. Hospitals & Transplant Centers

            13.10.2. Research Laboratories

            13.10.3. Others

        13.11. Market Attractiveness, by End-user

        13.12. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.12.1. Germany

            13.12.2. U.K.

            13.12.3. France

            13.12.4. Italy

            13.12.5. Spain

            13.12.6. Rest of Europe

        13.13. Market Attractiveness Analysis

            13.13.1. By Screening

            13.13.2. By Technique

            13.13.3. By Application

            13.13.4. By Products & Services

            13.13.5. By End-user

            13.13.6. By Country/Sub-region

    14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Screening, 2017–2031

            14.2.1. Pre-transplant Diagnostics

            14.2.2. Post-transplant Diagnostics

        14.3. Market Attractiveness, by Screening

        14.4. Market Value Forecast, by Technique, 2017–2031

            14.4.1. Molecular Assay

            14.4.2. Non-molecular Assay

        14.5. Market Attractiveness, by Technique

        14.6. Market Value Forecast, by Application, 2017–2031

            14.6.1. Solid Organ Transplantation

                14.6.1.1. Kidney

                14.6.1.2. Liver

                14.6.1.3. Heart

                14.6.1.4. Lungs

                14.6.1.5. Pancreas

                14.6.1.6. Small Bowel

            14.6.2. Stem Cell Transplantation

        14.7. Market Attractiveness, by Application

        14.8. Market Value Forecast, by Products & Services, 2017–2031

            14.8.1. Reagents & Consumables

            14.8.2. Instruments

            14.8.3. Software & Services

        14.9. Market Attractiveness, by Products & Services

        14.10. Market Value Forecast, by End-user, 2017–2031

            14.10.1. Hospitals & Transplant Centers

            14.10.2. Research Laboratories

            14.10.3. Others

        14.11. Market Attractiveness, by End-user

        14.12. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.12.1. China

            14.12.2. Japan

            14.12.3. India

            14.12.4. Australia & New Zealand

            14.12.5. Rest of Asia Pacific

        14.13. Market Attractiveness Analysis

            14.13.1. By Screening

            14.13.2. By Technique

            14.13.3. By Application

            14.13.4. By Products & Services

            14.13.5. By End-user

            14.13.6. By Country/Sub-region

    15. Latin America Transplant Diagnostics Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Screening, 2017–2031

            15.2.1. Pre-transplant Diagnostics

            15.2.2. Post-transplant Diagnostics

        15.3. Market Attractiveness, by Screening

        15.4. Market Value Forecast, by Technique, 2017–2031

            15.4.1. Molecular Assay

            15.4.2. Non-molecular Assay

        15.5. Market Attractiveness, by Technique

        15.6. Market Value Forecast, by Application, 2017–2031

            15.6.1. Solid Organ Transplantation

                15.6.1.1. Kidney

                15.6.1.2. Liver

                15.6.1.3. Heart

                15.6.1.4. Lungs

                15.6.1.5. Pancreas

                15.6.1.6. Small Bowel

            15.6.2. Stem Cell Transplantation

        15.7. Stem Cell Transplantation Market Attractiveness, by Application

        15.8. Market Value Forecast, by Products & Services, 2017–2031

            15.8.1. Reagents & Consumables

            15.8.2. Instruments

            15.8.3. Software & Services

        15.9. Market Attractiveness, by Products & Services

        15.10. Market Value Forecast, by End-user, 2017–2031

            15.10.1. Hospitals & Transplant Centers

            15.10.2. Research Laboratories

            15.10.3. Others

        15.11. Market Attractiveness, by End-user

        15.12. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.12.1. Brazil

            15.12.2. Mexico

            15.12.3. Rest of Latin America

        15.13. Market Attractiveness Analysis

            15.13.1. By Screening

            15.13.2. By Technique

            15.13.3. By Application

            15.13.4. By Products & Services

            15.13.5. By End-user

            15.13.6. By Country/Sub-region

    16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

        16.1. Introduction

            16.1.1. Key Findings

        16.2. Market Value Forecast, by Screening, 2017–2031

            16.2.1. Pre-transplant Diagnostics

            16.2.2. Post-transplant Diagnostics

        16.3. Market Attractiveness, by Screening

        16.4. Market Value Forecast, by Technique, 2017–2031

            16.4.1. Molecular Assay

            16.4.2. Non-molecular Assay

        16.5. Market Attractiveness, by Technique

        16.6. Market Value Forecast, by Application, 2017–2031

            16.6.1. Solid Organ Transplantation

                16.6.1.1. Kidney

                16.6.1.2. Liver

                16.6.1.3. Heart

                16.6.1.4. Lungs

                16.6.1.5. Pancreas

                16.6.1.6. Small Bowel

            16.6.2. Stem Cell Transplantation

        16.7. Market Attractiveness, by Application

        16.8. Market Value Forecast, by Products & Services, 2017–2031

            16.8.1. Reagents & Consumables

            16.8.2. Instruments

            16.8.3. Software & Services

        16.9. Market Attractiveness, by Products & Services

        16.10. Market Value Forecast, by End-user, 2017–2031

            16.10.1. Hospitals & Transplant Centers

            16.10.2. Research Laboratories

            16.10.3. Others

        16.11. Market Attractiveness, by End-user

        16.12. Market Value Forecast, by Country/Sub-region, 2017–2031

            16.12.1. GCC Countries

            16.12.2. South Africa

            16.12.3. Rest of Middle East & Africa

        16.13. Market Attractiveness Analysis

            16.13.1. By Screening

            16.13.2. By Technique

            16.13.3. By Application

            16.13.4. By Products & Services

            16.13.5. By End-user

            16.13.6. By Country/Sub-region

    17. Competition Landscape

        17.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        17.2. Market Share Analysis, by Company (2022)

        17.3. Company Profiles

            17.3.1. Bio-Rad laboratories, Inc.

                17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.1.2. Product Portfolio

                17.3.1.3. Financial Overview

                17.3.1.4. SWOT Analysis

                17.3.1.5. Strategic Overview

            17.3.2. Qiagen N.V.

                17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.2.2. Product Portfolio

                17.3.2.3. Financial Overview

                17.3.2.4. SWOT Analysis

                17.3.2.5. Strategic Overview

            17.3.3. F. Hoffmann-La Roche AG

                17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.3.2. Product Portfolio

                17.3.3.3. Financial Overview

                17.3.3.4. SWOT Analysis

                17.3.3.5. Strategic Overview

            17.3.4. Thermo Fisher Scientific, Inc.

                17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.4.2. Product Portfolio

                17.3.4.3. Financial Overview

                17.3.4.4. SWOT Analysis

                17.3.4.5. Strategic Overview

            17.3.5. Becton, Dickinson and Company

                17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.5.2. Product Portfolio

                17.3.5.3. Financial Overview

                17.3.5.4. SWOT Analysis

                17.3.5.5. Strategic Overview

            17.3.6. Ortho Clinical Diagnostics

                17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.6.2. Product Portfolio

                17.3.6.3. Financial Overview

                17.3.6.4. SWOT Analysis

                17.3.6.5. Strategic Overview

            17.3.7. Immucor, Inc.

                17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.7.2. Product Portfolio

                17.3.7.3. Financial Overview

                17.3.7.4. SWOT Analysis

                17.3.7.5. Strategic Overview

            17.3.8. Illumina, Inc.

                17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.8.2. Product Portfolio

                17.3.8.3. Financial Overview

                17.3.8.4. SWOT Analysis

                17.3.8.5. Strategic Overview

            17.3.9. Siemens Healthineers (Siemens AG)

                17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.9.2. Product Portfolio

                17.3.9.3. Financial Overview

                17.3.9.4. SWOT Analysis

                17.3.9.5. Strategic Overview

            17.3.10. Agilent Technologies

                17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                17.3.10.2. Product Portfolio

                17.3.10.3. Financial Overview

                17.3.10.4. SWOT Analysis

                17.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031

    Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031

    Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031

    Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031

    Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031

    Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031

    Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031

    Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031

    Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

    Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022

    Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022

    Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022

    Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022

    Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022

    Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022

    Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022

    Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022

    Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022

    Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022

    Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022

    Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

    Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031

    Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031

    Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022

    Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022

    Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022

    Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022

    Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031

    Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023-2031

    Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023–2031

    Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031

    Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

    Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

    Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031

    Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

    Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031

    Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

    Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031

    Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

    Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031

    Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031

    Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031

    Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031

    Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031

    Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031

    Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031

    Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031

    Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved